标题
Progress in Alzheimer’s disease
作者
关键词
-
出版物
JOURNAL OF NEUROLOGY
Volume 259, Issue 2, Pages 201-211
出版商
Springer Nature
发表日期
2011-06-26
DOI
10.1007/s00415-011-6145-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?
- (2017) Ana Martinez et al. JOURNAL OF ALZHEIMERS DISEASE
- Phosphorylated Tau: Toxic, Protective, or None of the Above
- (2017) Rudy J. Castellani et al. JOURNAL OF ALZHEIMERS DISEASE
- Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
- (2017) Ashley I. Bush JOURNAL OF ALZHEIMERS DISEASE
- Oxidative Stress in Diabetes and Alzheimer's Disease
- (2017) V. Prakash Reddy et al. JOURNAL OF ALZHEIMERS DISEASE
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
- (2012) Daniela Galimberti et al. CNS & Neurological Disorders-Drug Targets
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Preliminary Evidence of Validity of the Revised Criteria for Alzheimer Disease Diagnosis
- (2010) Giovanni B. Frisoni et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population
- (2010) F.H. Bouwman et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
- (2010) Richard Dodel et al. DRUGS
- Molecular mechanisms of neurodegeneration in Alzheimer's disease
- (2010) L. Crews et al. HUMAN MOLECULAR GENETICS
- Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis
- (2010) Celeste A de Jager et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
- (2010) S. W. Pimplikar et al. JOURNAL OF NEUROSCIENCE
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Report of the task force on designing clinical trials in early (predementia) AD
- (2010) P. S. Aisen et al. NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease
- (2008) Paul S. Aisen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Therapeutic Strategies for Alzheimer’s Disease
- (2008) Donna M. Barten et al. MOLECULAR NEUROBIOLOGY
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now